X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Clinical Trials News - 29/Jun 22:06

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of...

Articles similaires

New global research aims to improve survival rates for pancreatic cancer patients

oncologynews.com.au - 26/Jun 15:44

A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...

Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients

oncologynews.com.au - 25/Jun 12:37

An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...

Assessing clinical benefit and safety in trial waivers for treatment-refractory cancers

news.medical.net - 27/Jun 16:06

Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had...

Sorry! Image not available at this time

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia

drugs.com - 24/Jun 23:06

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

news.medical.net - 05/Jul 16:57

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the...

PharmAust raises cash for anti-cancer study

aumanufacturing.com.au - 23/Jun 16:07

Clinical stage biotechnology company PharmAust has received commitments to raise $10 million via an institutional placement with directors and...

Sorry! Image not available at this time

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

drugs.com - 01/Jul 06:07

STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused...

Sorry! Image not available at this time

Acupuncture Aids Sleep in Patients With Parkinson Disease

drugs.com - 05/Jul 14:38

FRIDAY, July 5, 2024 -- Acupuncture is associated with improved sleep quality in patients with Parkinson disease, according to a study published...

Sorry! Image not available at this time

Pulnovo Medical begins patient enrollment in Portugal for global study of PADN technology in treating pulmonary hypertension associated with left heart disease

pharmabiz.com - 03/Jul 00:00

Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of pulmonary hypertension (PH) and heart failure (HF), announced the...

Sorry! Image not available at this time

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

drugs.com - 02/Jul 15:07

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be...